Chimerix Depreciation & Amortization 2011-2026 | CMRX

Annual Depreciation & Amortization Chimerix

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
94 K	91 K	98 K	167 K	402 K	564 K	860 K	1.09 M	1.06 M	657 K	283 K	258 K	280 K	270 K	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
1.09 M	91 K	441 K

Quarterly Depreciation & Amortization Chimerix

2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
67 K	46 K	22 K	-	68 K	45 K	22 K	-	73 K	48 K	24 K	-	143 K	105 K	71 K	-	309 K	216 K	112 K	-	451 K	306 K	149 K	-	691 K	487 K	248 K	-	828 K	558 K	281 K	-	781 K	525 K	267 K	-	444 K	264 K	114 K	-	183 K	95 K	50 K	-	197 K	135 K	68 K	-	210 K	141 K	73 K	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
828 K	22 K	229 K

Depreciation & Amortization of other stocks in the Biotechnology industry

Issuer	Depreciation & Amortization	Price	% 24h	Market Cap	Country
Compugen Ltd. CGEN	475 K	$ 2.03	0.5 %	$ 190 M	Israel
Coherus BioSciences CHRS	1.3 M	$ 1.45	1.76 %	$ 170 M	USA
Happiness Biotech Group Limited HAPP	380 K	-	1.35 %	$ 17.8 M	China
AgeX Therapeutics AGE	100 K	-	-10.17 %	$ 12.2 K	USA
I-Mab IMAB	23.9 M	-	-	$ 866 M	China
Deciphera Pharmaceuticals DCPH	2.1 M	-	-	$ 2.18 B	USA
Alpine Immune Sciences ALPN	576 K	-	-	$ 2.17 B	USA
AstraZeneca PLC AZN	5.73 B	-	-	$ 96.9 B	Britain
Athira Pharma ATHA	972 K	-	-	$ 269 M	USA
Galera Therapeutics GRTX	20 K	-	-32.59 %	$ 7.61 M	USA
CRISPR Therapeutics AG CRSP	19.5 M	$ 52.3	1.59 %	$ 4.7 B	Schweiz
Checkmate Pharmaceuticals CMPI	66 K	-	-	$ 231 M	USA
Berkeley Lights BLI	9 M	-	-7.31 %	$ 87 M	USA
Celldex Therapeutics CLDX	3.38 M	$ 30.18	1.95 %	$ 2 B	USA
Generation Bio Co. GBIO	4.93 M	-	-	$ 344 M	USA
Akero Therapeutics AKRO	18 K	-	-	$ 3.67 B	USA
Akouos AKUS	2.49 M	-	0.23 %	$ 488 M	USA
Ayala Pharmaceuticals AYLA	162 K	-	-	$ 7.46 M	Israel
Cyclacel Pharmaceuticals CYCCP	5 K	-	-4.36 %	$ 27 M	USA
Freeline Therapeutics Holdings plc FRLN	1.74 M	-	-	$ 384 M	Britain
Gracell Biotechnologies GRCL	58.8 M	-	-	$ 3.37 B	China
Forte Biosciences FBRX	64 K	$ 17.62	3.65 %	$ 228 M	USA
Anika Therapeutics ANIK	5.37 M	$ 14.42	-1.06 %	$ 207 M	USA
Advaxis ADXS	369 K	-	-9.65 %	$ 45.9 M	USA
Aeterna Zentaris AEZS	58 K	-	5.93 %	$ 314 M	Canada
Aeglea BioTherapeutics AGLE	744 K	-	-	$ 1.01 B	USA
Applied Genetic Technologies Corporation AGTC	1.51 M	-	-	$ 26.5 M	USA
AIkido Pharma AIKI	105 K	-	1.93 %	$ 17.4 M	USA
Can-Fite BioPharma Ltd. CANF	24 K	$ 2.91	-1.69 %	$ 4.79 M	Israel
Aptose Biosciences APTO	22 K	-	-45.71 %	$ 1.2 M	Canada
Aptinyx APTX	122 K	-	-39.0 %	$ 4.57 M	USA
Albireo Pharma ALBO	274 K	-	-0.23 %	$ 916 M	USA
AlloVir ALVR	13 K	-	4.14 %	$ 49.1 M	USA
Allakos ALLK	7.72 M	-	-	$ 28.6 M	USA
Arcutis Biotherapeutics ARQT	700 K	$ 23.57	3.42 %	$ 3 B	USA